Report Detail
EMEA (Europe, Middle East and Africa) Lung Cancer Diagnostic Tests Market Report 2018
- RnM1775558 |
- 21 March, 2018 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
In this report, the EMEA Lung Cancer Diagnostic Tests market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Lung Cancer Diagnostic Tests for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Lung Cancer Diagnostic Tests market competition by top manufacturers/players, with Lung Cancer Diagnostic Tests sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Precision Medicine
Personalized Medicine
Cancer Monitoring
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Lung Cancer Diagnostic Tests Market Report 2018
1 Lung Cancer Diagnostic Tests Overview
- 1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
- 1.2 Classification of Lung Cancer Diagnostic Tests
- 1.2.1 EMEA Lung Cancer Diagnostic Tests Market Size (Sales) Comparison by Type (2013-2025)
- 1.2.2 EMEA Lung Cancer Diagnostic Tests Market Size (Sales) Market Share by Type (Product Category) in 2017
- 1.2.3 Immunoassays
- 1.2.4 Flow Cytometry
- 1.2.5 Rapid Tests
- 1.2.6 Molecular Assays
- 1.2.7 Tissue Arrays
- 1.2.8 Circulating Tumor Cells
- 1.2.9 Pharmacodiagnostics
- 1.2.10 Biomarkers
- 1.2.11 Other Diagnostics Methods
- 1.3 EMEA Lung Cancer Diagnostic Tests Market by Application/End Users
- 1.3.1 EMEA Lung Cancer Diagnostic Tests Sales (Volume) and Market Share Comparison by Application (2013-2025)
- 1.3.2 Precision Medicine
- 1.3.3 Personalized Medicine
- 1.3.4 Cancer Monitoring
- 1.4 EMEA Lung Cancer Diagnostic Tests Market by Region
- 1.4.1 EMEA Lung Cancer Diagnostic Tests Market Size (Value) Comparison by Region (2013-2025)
- 1.4.2 Europe Status and Prospect (2013-2025)
- 1.4.3 Middle East Status and Prospect (2013-2025)
- 1.4.4 Africa Status and Prospect (2013-2025)
- 1.5 EMEA Market Size (Value and Volume) of Lung Cancer Diagnostic Tests (2013-2025)
- 1.5.1 EMEA Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2025)
- 1.5.2 EMEA Lung Cancer Diagnostic Tests Revenue and Growth Rate (2013-2025)
2 EMEA Lung Cancer Diagnostic Tests Competition by Manufacturers/Players/Suppliers, Region, Type and Application
- 2.1 EMEA Lung Cancer Diagnostic Tests Market Competition by Players/Manufacturers
- 2.1.1 EMEA Lung Cancer Diagnostic Tests Sales Volume and Market Share of Major Players (2013-2018)
- 2.1.2 EMEA Lung Cancer Diagnostic Tests Revenue and Share by Players (2013-2018)
- 2.1.3 EMEA Lung Cancer Diagnostic Tests Sale Price by Players (2013-2018)
- 2.2 EMEA Lung Cancer Diagnostic Tests (Volume and Value) by Type/Product Category
- 2.2.1 EMEA Lung Cancer Diagnostic Tests Sales and Market Share by Type (2013-2018)
- 2.2.2 EMEA Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2013-2018)
- 2.2.3 EMEA Lung Cancer Diagnostic Tests Sale Price by Type (2013-2018)
- 2.3 EMEA Lung Cancer Diagnostic Tests (Volume) by Application
- 2.4 EMEA Lung Cancer Diagnostic Tests (Volume and Value) by Region
- 2.4.1 EMEA Lung Cancer Diagnostic Tests Sales and Market Share by Region (2013-2018)
- 2.4.2 EMEA Lung Cancer Diagnostic Tests Revenue and Market Share by Region (2013-2018)
- 2.4.3 EMEA Lung Cancer Diagnostic Tests Sales Price by Region (2013-2018)
3 Europe Lung Cancer Diagnostic Tests (Volume, Value and Sales Price), by Players, Countries, Type and Application
- 3.1 Europe Lung Cancer Diagnostic Tests Sales and Value (2013-2018)
- 3.1.1 Europe Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2013-2018)
- 3.1.2 Europe Lung Cancer Diagnostic Tests Revenue and Growth Rate (2013-2018)
- 3.2 Europe Lung Cancer Diagnostic Tests Sales and Market Share by Type
- 3.3 Europe Lung Cancer Diagnostic Tests Sales and Market Share by Application
- 3.4 Europe Lung Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
- 3.4.1 Europe Lung Cancer Diagnostic Tests Sales Volume by Countries (2013-2018)
- 3.4.2 Europe Lung Cancer Diagnostic Tests Revenue by Countries (2013-2018)
- 3.4.3 Germany Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 3.4.4 France Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 3.4.5 UK Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 3.4.6 Russia Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 3.4.7 Italy Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 3.4.8 Benelux Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
4 Middle East Lung Cancer Diagnostic Tests (Volume, Value and Sales Price), by Region, Type and Application
- 4.1 Middle East Lung Cancer Diagnostic Tests Sales and Value (2013-2018)
- 4.1.1 Middle East Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2013-2018)
- 4.1.2 Middle East Lung Cancer Diagnostic Tests Revenue and Growth Rate (2013-2018)
- 4.2 Middle East Lung Cancer Diagnostic Tests Sales and Market Share by Type
- 4.3 Middle East Lung Cancer Diagnostic Tests Sales and Market Share by Application
- 4.4 Middle East Lung Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
- 4.4.1 Middle East Lung Cancer Diagnostic Tests Sales Volume by Countries (2013-2018)
- 4.4.2 Middle East Lung Cancer Diagnostic Tests Revenue by Countries (2013-2018)
- 4.4.3 Saudi Arabia Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 4.4.4 Israel Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 4.4.5 UAE Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 4.4.6 Iran Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
5 Africa Lung Cancer Diagnostic Tests (Volume, Value and Sales Price) by Players, Countries, Type and Application
- 5.1 Africa Lung Cancer Diagnostic Tests Sales and Value (2013-2018)
- 5.1.1 Africa Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2013-2018)
- 5.1.2 Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (2013-2018)
- 5.2 Africa Lung Cancer Diagnostic Tests Sales and Market Share by Type
- 5.3 Africa Lung Cancer Diagnostic Tests Sales and Market Share by Application
- 5.4 Africa Lung Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
- 5.4.1 Africa Lung Cancer Diagnostic Tests Sales Volume by Countries (2013-2018)
- 5.4.2 Africa Lung Cancer Diagnostic Tests Revenue by Countries (2013-2018)
- 5.4.3 South Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 5.4.4 Nigeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 5.4.5 Egypt Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
- 5.4.6 Algeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2018)
6 EMEA Lung Cancer Diagnostic Tests Manufacturers/Players Profiles and Sales Data
- 6.1 Advpharma Inc
- 6.1.1 Company Basic Information, Manufacturing Base and Competitors
- 6.1.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.1.2.1 Product A
- 6.1.2.2 Product B
- 6.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.1.4 Main Business/Business Overview
- 6.2 AIT Austrian Institute of Technology GmbH
- 6.2.1 Company Basic Information, Manufacturing Base and Competitors
- 6.2.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.2.2.1 Product A
- 6.2.2.2 Product B
- 6.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.2.4 Main Business/Business Overview
- 6.3 Courtagen Life Sciences Inc
- 6.3.1 Company Basic Information, Manufacturing Base and Competitors
- 6.3.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.3.2.1 Product A
- 6.3.2.2 Product B
- 6.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.3.4 Main Business/Business Overview
- 6.4 DiagnoCure Inc. (Inactive)
- 6.4.1 Company Basic Information, Manufacturing Base and Competitors
- 6.4.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.4.2.1 Product A
- 6.4.2.2 Product B
- 6.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.4.4 Main Business/Business Overview
- 6.5 BioMark Diagnostics Inc.
- 6.5.1 Company Basic Information, Manufacturing Base and Competitors
- 6.5.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.5.2.1 Product A
- 6.5.2.2 Product B
- 6.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.5.4 Main Business/Business Overview
- 6.6 BioMarker Strategies LLC
- 6.6.1 Company Basic Information, Manufacturing Base and Competitors
- 6.6.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.6.2.1 Product A
- 6.6.2.2 Product B
- 6.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.6.4 Main Business/Business Overview
- 6.7 Emory University
- 6.7.1 Company Basic Information, Manufacturing Base and Competitors
- 6.7.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.7.2.1 Product A
- 6.7.2.2 Product B
- 6.7.3 Emory University Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.7.4 Main Business/Business Overview
- 6.8 Epigenomics AG
- 6.8.1 Company Basic Information, Manufacturing Base and Competitors
- 6.8.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.8.2.1 Product A
- 6.8.2.2 Product B
- 6.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.8.4 Main Business/Business Overview
- 6.9 GlycoZym
- 6.9.1 Company Basic Information, Manufacturing Base and Competitors
- 6.9.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.9.2.1 Product A
- 6.9.2.2 Product B
- 6.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.9.4 Main Business/Business Overview
- 6.10 HalioDx SAS
- 6.10.1 Company Basic Information, Manufacturing Base and Competitors
- 6.10.2 Lung Cancer Diagnostic Tests Product Type, Application and Specification
- 6.10.2.1 Product A
- 6.10.2.2 Product B
- 6.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
- 6.10.4 Main Business/Business Overview
- 6.11 Louisville Bioscience, Inc.
- 6.12 Mayo Clinic US
7 Lung Cancer Diagnostic Tests Manufacturing Cost Analysis
- 7.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Price Trend of Key Raw Materials
- 7.1.3 Key Suppliers of Raw Materials
- 7.1.4 Market Concentration Rate of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.2.1 Raw Materials
- 7.2.2 Labor Cost
- 7.2.3 Manufacturing Expenses
- 7.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
- 8.1 Lung Cancer Diagnostic Tests Industrial Chain Analysis
- 8.2 Upstream Raw Materials Sourcing
- 8.3 Raw Materials Sources of Lung Cancer Diagnostic Tests Major Manufacturers in 2017
- 8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.1.3 Marketing Channel Development Trend
- 9.2 Market Positioning
- 9.2.1 Pricing Strategy
- 9.2.2 Brand Strategy
- 9.2.3 Target Client
- 9.3 Distributors/Traders List
10 Market Effect Factors Analysis
- 10.1 Technology Progress/Risk
- 10.1.1 Substitutes Threat
- 10.1.2 Technology Progress in Related Industry
- 10.2 Consumer Needs/Customer Preference Change
- 10.3 Economic/Political Environmental Change
11 EMEA Lung Cancer Diagnostic Tests Market Forecast (2018-2025)
- 11.1 EMEA Lung Cancer Diagnostic Tests Sales, Revenue and Price Forecast (2018-2025)
- 11.1.1 EMEA Lung Cancer Diagnostic Tests Sales and Growth Rate Forecast (2018-2025)
- 11.1.2 EMEA Lung Cancer Diagnostic Tests Revenue and Growth Rate Forecast (2018-2025)
- 11.1.3 EMEA Lung Cancer Diagnostic Tests Price and Trend Forecast (2018-2025)
- 11.2 EMEA Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
- 11.3 Europe Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
- 11.4 Middle Eastt Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
- 11.5 Africa Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
- 11.6 EMEA Lung Cancer Diagnostic Tests Sales Forecast by Type (2018-2025)
- 11.7 EMEA Lung Cancer Diagnostic Tests Sales Forecast by Application (2018-2025)
12 Research Findings and Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
